Zobrazeno 1 - 3
of 3
pro vyhledávání: '"S. Prasad"'
Autor:
Patel KB; Department of Medical and Paediatric Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India., Panchal HP, Karanwal AB, Parekh BB, Shah S, Prasad S
Publikováno v:
Indian journal of cancer [Indian J Cancer] 2016 Jan-Mar; Vol. 53 (1), pp. 118-22.
Autor:
Ahmad M; Department of Medical Oncology, Apollo Cancer Hospital, Apollo Health City, Jubilee Hills, Hyderabad, Telangana, India., Prasad S, Krishna MV, Lavingia V
Publikováno v:
Indian journal of cancer [Indian J Cancer] 2016 Jan-Mar; Vol. 53 (1), pp. 112-3.
Publikováno v:
Indian Journal of Cancer. 53:118
The 5-year survival rate for metastatic renal cell carcinoma (RCC) is estimated to be10%. RCC is highly resistant to chemotherapy. Targeted agents are now first choice of therapy for metastatic RCC such as sunitinib and sorafenib.This study is a retr